Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Change in Receivables (2019 - 2025)

BioNexus Gene Lab's Change in Receivables history spans 7 years, with the latest figure at -$944701.0 for Q4 2025.

  • Quarterly results put Change in Receivables at -$944701.0 for Q4 2025, down 32924.91% from a year ago — trailing twelve months through Dec 2025 was -$782841.0 (down 429.81% YoY), and the annual figure for FY2025 was -$782841.0, down 429.81%.
  • Change in Receivables for Q4 2025 was -$944701.0 at BioNexus Gene Lab, down from -$206475.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $1.2 million in Q4 2022 to a low of -$944701.0 in Q4 2025.
  • The 5-year median for Change in Receivables is -$112544.0 (2024), against an average of $41903.6.
  • The sharpest move saw Change in Receivables surged 713.03% in 2024, then plummeted 32924.91% in 2025.
  • Year by year, Change in Receivables stood at $777770.0 in 2021, then skyrocketed by 51.34% to $1.2 million in 2022, then decreased by 1.75% to $1.2 million in 2023, then plummeted by 99.75% to $2878.0 in 2024, then plummeted by 32924.91% to -$944701.0 in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$944701.0, -$206475.0, and $480950.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.